Florida · 86053

Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody in Florida

Florida Medicare Avg
$34.68
4% below national avg
National Medicare Avg
$36.04
All states combined
Billed Charge (FL)
$230.00
What providers submit
Est. Commercial (FL)
$81.50
National avg: $80.73
Est. Cash / Self-Pay (FL)
$89.26
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

34
Services in FL
1
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Florida

Provider Medicare Services
Mayo Clinic Jacksonville $34.68 34

Florida Pricing in Context

In Florida, CPT code 86053 (Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody) carries an average Medicare payment of $34.68 — 4% below the national benchmark of $36.04. 1 providers across the state submitted claims for this procedure in 2023, performing 34 total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Florida is $230.00, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Florida lands near $81.50, with self-pay cash prices typically around $89.26. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody cost in Florida?

The average Medicare payment for Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody in Florida is $34.68, which is 4% below the national average of $36.04. Providers in FL typically bill $230.00 for this procedure.

What does Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody cost with insurance in Florida?

With commercial insurance in Florida, Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody costs an estimated $81.50. Without insurance, the estimated cash price is $89.26. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody in Florida?

1 providers in Florida billed Medicare for Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody in 2023, performing 34 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody cheaper in Florida than the national average?

Yes — Flow Cytometry Detection Of Aquaporin-4 (neuromyelitis Optica [nmo]) Antibody costs 4% below the national average in Florida. The state average Medicare payment is $34.68 compared to $36.04 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial